IMARC Group, a leading market research company, has recently releases report titled " Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the global blood plasma derivatives market growth, share, size trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report HighlightsHow Big is the Blood Plasma Derivatives Market?The global blood plasma derivatives market size reached US$ 43.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.
What is Blood Plasma Derivatives?Blood plasma derivatives refer to a concentrated form of specific proteins produced from plasma that is obtained through the fractionation process. They can be categorized into various types, such as Factor VIII, albumin, immunoglobulin, factor IX, fresh frozen, etc. Blood plasma derivatives are rich in minerals, proteins, salts, hormones, vitamins, and protease inhibitors, owing to which they are extensively utilized to kill viruses that cause hemophilia A, hepatitis B, immunodeficiency, bleeding disorders, hepatitis C, hemophilia B, human immunodeficiency virus (HIV), etc. Blood plasma derivatives also help in controlling the body temperature, improving nutrition, maintaining osmotic pressure, regulating acid-base balance, and enhancing respiration and excretion processes. Consequently, they find widespread applications in hospitals, clinics, and other healthcare facilities across countries.
Request for a free sample copy of this report: What are the growth prospects and trends in the Blood Plasma Derivatives Industry?https://www.imarcgroup.com/blood-plasma-derivatives-market/requestsampleThe growing geriatric population, which is relatively more susceptible to developing infectious diseases, and the expanding incidences of thrombocytosis are among the key factors augmenting the blood plasma derivatives market.
Additionally, the development of numerous advanced technologies in the fractionation process, which improves the separation of protein concentrates and several other components of blood plasma for clinical purposes, is further catalyzing the market growth. Besides this, the escalating adoption of convalescent plasma treatments to treat patients suffering from COVID-19 is acting as another significant growth-inducing factor.
What is included in market segmentation?Furthermore, the introduction of superior preservation methods and the increasing advancements in encased procedures to develop targeted therapeutic products are expected to stimulate the blood plasma derivatives market in the coming years.
Breakup by Type:The report has segmented the market into the following categories:
Breakup by Application:- Albumin
- Factor VIII
- Factor IX
- Immunoglobulin
- Hyperimmune Globulin
- Others
- Hemophilia
- Hypogammaglobulinemia
- Immunodeficiency Diseases
- Von Willebrand's Disease
- Others
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
The report covers the major market players including:
Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.About UsAsk Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5371&flag=C
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact USIMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
